Explore

Rapid Read Rapid Read
President Trump's Drug Tariffs Could Impact U.S. Generic Medicine Supply

President Trump's Drug Tariffs Could Impact U.S. Generic Medicine Supply

President Trump has announced a plan to impose tariffs on imported generic drugs, starting with a 100% tariff in 2028 and increasing to 200% in 2029. The policy aims to encourage domestic pharmaceutical production by making it more costly to import generics. However, experts warn that this could lead to shortages and increased costs for patients, as the U.S. heavily relies on imports for generic drugs. Currently, about 50% of generic drugs in the U.S. are manufactured in India, and 17% of active pharmaceutical ingredients come from China. The tariffs could drive foreign manufacturers out of the U.S. market, exacerbating existing drug shortages and potentially increasing reliance on more expensive branded drugs.
Rapid Read Rapid Read
House Republicans Subpoena Left-Wing Groups Amid Trump Administration Crackdown

House Republicans Subpoena Left-Wing Groups Amid Trump Administration Crackdown

House Republicans, led by the Ways and Means Committee, have issued subpoenas to three left-wing organizations, including BreakThrough News and The People's Forum. This action is part of a broader effort by the Trump administration to scrutinize left-wing movements, which they allege are influenced by foreign entities. The subpoenas demand financial and communication records to investigate potential funding from Neville Roy Singham, a businessman under investigation for alleged ties to China. The committee, chaired by Jason Smith, aims to determine if legislative reforms are needed to address gaps in existing laws regarding foreign influence in tax-exempt organizations.
Rapid Read Rapid Read
White House Proposes Major Shift in Research Funding Towards AI and Individual Scientists

White House Proposes Major Shift in Research Funding Towards AI and Individual Scientists

The Trump administration has proposed reallocating $200 billion in research funding from universities and peer-reviewed panels to individual scientists and AI-native laboratories. This initiative, outlined in a report titled 'Science: A New Golden Age,' aims to position the U.S. as a leader in AI and quantum computing. The plan, presented by Michael Kratsios, Director of the White House Office of Science and Technology Policy, seeks to move away from traditional peer review processes to foster groundbreaking scientific work. However, the proposal has been met with skepticism due to concerns about the credibility of U.S. scientific research and the environmental impact of AI data centers.
Trendline Trendline
Former DOGE Staffers Launch Cybersecurity Startup Cathedral with $1.4 Billion Valuation

Former DOGE Staffers Launch Cybersecurity Startup Cathedral with $1.4 Billion Valuation

Former DOGE Staffers Launch Cybersecurity Startup Cathedral with $1.4 Billion Valuation
Reuters Reuters
Trump imposes forced labor duties on 60 trading partners as  10% US tariffs expire

Trump imposes forced labor duties on 60 trading partners as  10% US tariffs expire

By David Lawder WASHINGTON, July 24 (Reuters) - The Trump administration on Friday imposed new tariffs of 10% and 12.5% on goods from 60 trading partners, including the European Union and China, over allegations of lax enforcement of forced labor bans, just as a temporary 10% global tariff expired.
Reuters Reuters
US, Mexico set more USMCA talks for September amid differences over autos content

US, Mexico set more USMCA talks for September amid differences over autos content

By Emily Green and David Lawder MEXICO CITY, July 23 (Reuters) - U.S. and Mexican officials said on Thursday they will meet for a fourth round of negotiations to revamp the North American trade pact in September, after talks this week exposed disagreements over changes to automotive content rules
Trendline Trendline
End of De Minimis Exemption Alters U.S. Import Strategies for SMBs

End of De Minimis Exemption Alters U.S. Import Strategies for SMBs

End of De Minimis Exemption Alters U.S. Import Strategies for SMBs
Reuters Reuters
US to spend $5 billion on health, construction research powered by AI

US to spend $5 billion on health, construction research powered by AI

By Courtney Rozen WASHINGTON, July 22 (Reuters) - The U.S. will spend $5 billion to tackle long-standing scientific problems across multiple fields using AI, the Trump administration said in a statement on Wednesday. 
Rolling Stone Rolling Stone
Trump’s CDC Is Detaining Americans in Response to Ebola: A ‘Wild Misuse’ of Power

Trump’s CDC Is Detaining Americans in Response to Ebola: A ‘Wild Misuse’ of Power

Rolling Stone obtained meeting notes highlighting how Jay Bhattacharya created a crisis trying to appease the White House
Reuters Reuters
Biotech experts want FDA drug reviews based on science, not politics

Biotech experts want FDA drug reviews based on science, not politics

By Deena Beasley July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U.S.
Reuters Reuters
Generic drugmaker Sandoz to engage with US after Trump tariff threat

Generic drugmaker Sandoz to engage with US after Trump tariff threat

By Marleen Kaesebier ZURICH, July 22 (Reuters) - Swiss generic drugmaker Sandoz said on Wednesday it would continue discussions with policymakers after U.S. President Donald Trump threatened the industry with steep tariffs unless drugmakers manufacture medicines domestically.
Trendline Trendline
OpenAI CEO Sam Altman to Brief Trump Administration on Next-Gen AI Models

OpenAI CEO Sam Altman to Brief Trump Administration on Next-Gen AI Models

OpenAI CEO Sam Altman to Brief Trump Administration on Next-Gen AI Models